Peter Kolchinsky - Jun 17, 2021 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role
Director, 10%+ Owner
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol
FMTX
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 07:01 PM
Next filing
Jun 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction FMTX Common Stock Award $0 +2.75K $0.00 2.75K Jun 17, 2021 Direct F1, F2
holding FMTX Common Stock 9.01M Jun 17, 2021 See footnote F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FMTX Stock Option (Right to Buy) Award $0 +8.38K $0.00 8.38K Jun 17, 2021 Common Stock 8.38K $25.35 Direct F2, F5

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2 Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option and restricted share units for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon sale of the common stock underlying the option and restricted share units, which will offset advisory fees owed by the Fund and the Nexus Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option, restricted share units and the underlying common stock.
F3 Includes (a) 7,500,226 shares held by the Fund and (b) 1,511,425 shares held by the Nexus Fund.
F4 The Adviser is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which the Reporting Person and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Reporting Person and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F5 This option shall vest and become exercisable in full upon the earlier to occur of (i) June 17, 2022 and (ii) the next annual meeting of the Issuer's stockholders.